Medicare Enrolled

Dr. Patrick Reilly, MD

Gastroenterology · Pensacola, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
4531 N DAVIS HWY, Pensacola, FL 32503
8504364563
In practice since 2006 (19 years)
NPI: 1568559938 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Reilly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Reilly? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Reilly

Dr. Patrick Reilly is a gastroenterology in Pensacola, FL, with 19 years in practice. Based on federal Medicare data, Dr. Reilly performed 8,150 Medicare services across 985 unique beneficiaries.

Between the years covered by Open Payments, Dr. Reilly received a total of $6,233 from 27 pharmaceutical and/or device companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Reilly is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 3% volume in FL$ $6,233 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,150
Medicare services
Top 3% in FL for gastroenterology
985
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~429 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Vedolizumab infusion (Entyvio)6,000$17$52
Infliximab infusion (Remicade)1,060$27$231
Upper GI endoscopy with biopsy193$68$1,183
Hospital follow-up visit, moderate complexity125$63$237
Colonoscopy with biopsy124$89$1,497
Office visit, established patient (30-39 min)122$91$348
Removal of polyps or growths of large bowel using an endoscope with mechanical snare101$204$1,426
Initial hospital admission, moderate complexity61$103$455
Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope54$177$954
Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope53$208$938
Dilation of esophagus42$32$866
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes37$66$343
Hospital follow-up visit, low complexity36$40$131
New patient office visit (45-59 min)27$126$542
Administration of chemotherapy into vein, 1 hour or less22$94$1,000
Colorectal cancer screening; colonoscopy on individual at high risk22$179$1,086
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less21$49$223
Administration of chemotherapy into vein, each additional hour19$22$300
Diagnostic exam of large bowel using a flexible endoscope16$138$1,500
Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope15$130$2,150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
86.9% high complexity
6.0% medium
7.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,233
Total received (2018-2024)
Avg $890/year across 7 years
Top 28% in FL for gastroenterology
27
Companies
233
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,233 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,173
2023
$2,113
2022
$881
2021
$565
2020
$321
2019
$377
2018
$804

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,161
Medtronic, Inc.
$1,058
Janssen Biotech, Inc.
$695
Takeda Pharmaceuticals U.S.A., Inc.
$484
AbbVie, Inc.
$466
Boston Scientific Corporation
$357
AbbVie Inc.
$351
Phathom Pharmaceuticals, Inc.
$247
Covidien LP
$166
Nestle HealthCare Nutrition Inc.
$162
Cook Medical LLC
$156
PFIZER INC.
$144
E.R. Squibb & Sons, L.L.C.
$133
Celgene Corporation
$117
Lilly USA, LLC
$88
Lumendi LLC
$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$67
Janssen Scientific Affairs, LLC
$66
Shionogi Inc
$62
Ferring Pharmaceuticals Inc.
$49
Merck Sharp & Dohme LLC
$24
Amgen Inc.
$20
Axonics, Inc.
$18
Ironwood Pharmaceuticals, Inc
$16
Olympus America Inc.
$15
Allergan Inc.
$15
Gilead Sciences, Inc.
$12
Top 3 companies account for 46.7% of total payments
Associated products mentioned in payments ›
AVSOLA · Axonics · CLENPIQ · COOK MEDICAL ENDOSCOPIC ULTRASOUND · CREON · Creon · DIFICID · Dexilant · DiLumen · ENTYVIO · EVIS EXERA III COLONOVIDEOSCOPE · EXALT Model D · EndoFlip · Entyvio · GATTEX · GENERAL BILIARY DEVICES · GENERAL THERAPIES · HUMIRA · Humira · INTERSTIM · Instinct · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Mulpleta · OMVOH · REBYOTA · RINVOQ · SKYRIZI · STELARA · SpyGlass · TREMFYA · VALIANT CAPTIVIA · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $76 per 100 Medicare services performed
Looking for a gastroenterology in Pensacola?
Compare gastroenterologys in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologys nearby

Geographic Context

Gastroenterologys within 10 mi
27
Per 100K population
8.4
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Reilly is a mixed practice specialist, with above-average Medicare volume (top 3% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Reilly experienced with vedolizumab infusion (entyvio)?
Based on Medicare claims data, Dr. Reilly performed 6,000 vedolizumab infusion (entyvio) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Reilly receive payments from pharmaceutical companies?
Yes. Dr. Reilly received a total of $6,233 from 27 companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Reilly's costs compare to other gastroenterologys in Pensacola?
Dr. Reilly's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Reilly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →